Peptide fragment of LYVE-1 and antibody against the same

Details Peptide fragment of LYVE-1 and antibody against the same Peptide fragment of LYVE-1 and antibody against the same

2004-03-11

2008-03-04

Foley, Shanon (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S300000

Reexamination Certificate

active

07339022

ABSTRACT:
It is intended to provide a specific peptide fragment of LYVE-1 which can serve as an epitope of a lymphatic vessel-specific antibody, and an antibody recognizing the above peptide fragment. A peptide fragment comprising an amino acid sequence:Ser Lys Lys Thr Asp Lys Asn Pro Glu Glu Ser Lys, or the peptide fragment in which an amino acid as a linker to the C-terminal or the N-terminal thereof is added.

REFERENCES:
patent: 5942417 (1999-08-01), Ni et al.
patent: 6368794 (2002-04-01), Daniel et al.
patent: 2002/0119130 (2002-08-01), Eaton et al.
patent: WO-03/006104 (2003-01-01), None
Puri et al., J Immunol, vol. 139, 2996-3002, 1987.
Laakkonen et al., Nature Medicine, vol. 8, p. 751-755, 2002.
Prevo et al., JBC, vol. 276, p. 19420-19430.
Abbas et al., cellular and molecular immunology, 4th edition, 2000.
Prevo et al., JBC, vol. 276, p. 19420-19430, 2001.
International Search Report dated May 18, 2004, 6 pages.
Jackson, D.G., “The Lymphatics Revisited: New Perspectives from the Hyaluronan Receptor LYVE-1,” Trends Cardiovasc Med., Jan. 2003; 13(1):1-7 (7 pages).
Straume, O., et al., “Independent Prognostic Impact of Lymphatic Vessel Density and Presence of Low-Grade Lymphangiogenesis in Cutaneous Melanoma,” Clin. Cancer Res., Jan. 2003; 9(1):250-6 (7 pages).
Cursiefen, C., et al., “Lymphatic Vessels in Vascularized Human Corneas: Immunohistochemical Investigation Using LYVE-1 and Podoplanin,” Investigative Ophthalmology & Visual Science, 2003, vol. 43, No. 7, pp. 2127-2135 (9 pages).
Akishima, Y., et al., “Immunohistochemical Detection of Human Small Lymphatic Vessels Undeer Normal and Pathological Conditions Using the LYVE-1 Antibody,” Virchows Arch., Feb. 2004, 444(2):153-7 (5 pages).
Supplementary European Search Report for Application No. EP04719660 dated May 24, 2006 (2 pages).
Banerji Suneale et al.: “Lyve-1, a new homologue of the CD44 glycoprotien, is a Lymph-specific receptor for hyaluronan,” The Journal of Cell Biology, Rockefeller University Press, US, vol. 144, No. 4, Feb. 22, 1999, pp. 789-801 (13 pages).
DATABASE Geneseq (online), Dec. 10, 2002, “Human secreted/tansmembrane protein PRO263”, retrieved from EBI accession No. GSN: ABG95853, Database accession No. ABG95853 (9 pages).
Podgrabinska, Simona et al: “Molecular characterization of lymphatic endotherlial cells,” Dec. 10, 2002) Proceedings of the National Academy of Sciences of the United States of America, vol. 99, NR. 25, pp. 16069-16074 (6 pages).

Affiliated with

Also associated with

Rating

Peptide fragment of LYVE-1 and antibody against the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide fragment of LYVE-1 and antibody against the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide fragment of LYVE-1 and antibody against the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3974913